Details for New Drug Application (NDA): 212593
✉ Email this page to a colleague
The generic ingredient in VASOPRESSIN is vasopressin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for 212593
Tradename: | VASOPRESSIN |
Applicant: | Am Regent |
Ingredient: | vasopressin |
Patents: | 0 |
Pharmacology for NDA: 212593
Physiological Effect | Decreased Diuresis Vasoconstriction |
Suppliers and Packaging for NDA: 212593
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 212593 | NDA | American Regent, Inc. | 0517-1020 | 0517-1020-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0517-1020-25) / 1 mL in 1 VIAL, SINGLE-DOSE (0517-1020-01) |
VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 212593 | NDA | American Regent, Inc. | 0517-1030 | 0517-1030-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0517-1030-01) / 10 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20UNITS/ML (20UNITS/ML) | ||||
Approval Date: | Aug 3, 2020 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 200UNITS/10ML (20UNITS/ML) | ||||
Approval Date: | Jun 9, 2023 | TE: | RLD: | Yes |
Complete Access Available with Subscription